Latest AI and machine learning research in atherosclerosis for healthcare professionals.
BACKGROUND: Artificial intelligence-enabled coronary plaque analysis (AI-CPA) has been shown to improve cardiovascular risk prediction. However, little is known about how these measures influence management. OBJECTIVES: This study sought to define changes in management guided by AI-CPA as compared with management guided by measures of nonobstructive and obstructive stenosis on coronary computed to...
Vascular Endothelial Growth Factor (VEGF) plays a central role in angiogenesis, regulating both physiological processes such as wound healing, tissue repair, and bone formation, and pathological events including tumor progression, metastasis, and diabetic retinopathy. Due to its crucial role in vascular biology, VEGF serves as an important therapeutic target in anti-angiogenic drug development and...
Dysregulated lipid metabolism is a key driver of follicular lymphoma (FL). This study aimed to explore the lipid metabolism-related genes (LMRGs) and ...
Clear cell renal cell carcinoma (ccRCC) is characterized by high metastatic potential and frequent resistance to conventional therapies, highlighting ...
BACKGROUND: Accurate estimation of low-density lipoprotein cholesterol (LDL-C) is essential for cardiovascular risk assessment and monitoring. Because...
ConspectusTranscytosis, traditionally regarded as biological, constitutes an intrinsic and powerful pathway for macromolecule transport across endothe...
BACKGROUND: Neovascular age-related macular degeneration (nAMD) shows a heterogeneous treatment response to anti-vascular endothelial growth factor (V...
Growing evidence implicates solute carrier (SLC) superfamily in atherosclerosis (AS) pathogenesis. This study identified SLC22A3 as a novel AS biomark...
Machine learning enables scalable quantification of neuropathology, offering deeper phenotyping of Alzheimer's disease (AD). In this validation study,...
BACKGROUND: Systemic lupus erythematosus (SLE) shows clinical and molecular heterogeneity, and cardiovascular (CV) complications and lupus nephritis (...
Antihypertensive peptides (AHTPs) are short-chain peptides derived from food or bioproteins through enzymatic hydrolysis, fermentation, or chemical sy...
BACKGROUND AND AIMS: Conventional biomarkers such as low-density lipoprotein (LDL) and high-density lipoprotein may fail to identify patients' risk fo...
BACKGROUND AND OBJECTIVE: Cerebral aneurysms affect 2-5% of the global population and pose a significant health risk upon rupture. While computational...
Fibrosis is a maladaptive pathophysiological process characterized by excessive deposition of extracellular matrix resulting from dysregulated tissue ...
Emerging organic pollutants (EOPs) are increasingly detected in wastewater and pose potential vascular toxicity risks that remain inadequately assesse...
Fibromuscular dysplasia (FMD) is a non-atherosclerotic vascular disorder with heterogeneous presentations, making diagnosis and management highly depe...
Artificial intelligence (AI) is reshaping cardiovascular imaging, transforming it from a set of diagnostic tests into powerful tools of precision medi...
BACKGROUND AND AIMS: Pulmonary arterial hypertension (PAH) is a severe disease with limited effective therapies, making the discovery of new therapeut...